Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Intense pulsed light (IPL) is an efficient and safe method for hair removal, reducing hair by about 80%.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

Plant-based drugs are effective and safe alternatives for managing PCOS symptoms.

Engineered extracellular vesicles show promise for targeted therapy but need more research for clinical use.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

Radiofrequency exposure can stimulate hair growth by increasing IGF-1 in hair follicle cells.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Meis1 is crucial for skin health and tumor development.

Minoxidil may protect nerves and improve hair quality during paclitaxel treatment.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

Runx1 controls fat-related genes important for normal and cancer cell growth, affecting skin and hair cell behavior.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.